Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 9/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.61 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.61 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.61 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.61 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.61 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.61 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.61 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.61 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.61 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.61 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2360214 | 1.00 | CHRM3 (0.61) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| SCHEMBL2360215 | 1.00 | CHRM3 (0.61) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| SCHEMBL25606483 | 0.82 | NOTUM (0.46) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| SCHEMBL9602318 | 0.80 | CHRM3 (0.58) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| SCHEMBL30132306 | 0.79 | NOTUM (0.57) | — | |
| SCHEMBL28825998 | 0.77 | KEAP1 (0.61) | — | |
| Solifenacin SCHEMBL1735698 | 0.76 | CHRM3 (1.00) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| Solifenacin SCHEMBL1478523 | 0.76 | CHRM3 (1.00) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| Solifenacin SCHEMBL13298567 | 0.76 | CHRM3 (1.00) | CHRM3CHRM2CHRM1KCNH2CACNA1F | |
| Solifenacin SCHEMBL1566459 | 0.76 | CHRM3 (1.00) | CHRM3CHRM2CHRM1KCNH2CACNA1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3724188-B1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2023-06-07 | — | — | EP | disclosed |
| WO-2019118528-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2019-06-20 | — | — | WO | disclosed |